The long noncoding RNA ROCKI regulates inflammatory gene expression
Long noncoding RNAs (lncRNAs) can regulate target gene expression by acting in cis (locally) or in trans (non‐locally). Here, we performed genome‐wide expression analysis of Toll‐like receptor (TLR)‐stimulated human macrophages to identify pairs of cis ‐acting lncRNAs and protein‐coding genes involv...
Gespeichert in:
Veröffentlicht in: | The EMBO journal 2019-04, Vol.38 (8), p.n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Long noncoding RNAs (lncRNAs) can regulate target gene expression by acting in
cis
(locally) or in
trans
(non‐locally). Here, we performed genome‐wide expression analysis of Toll‐like receptor (TLR)‐stimulated human macrophages to identify pairs of
cis
‐acting lncRNAs and protein‐coding genes involved in innate immunity. A total of 229 gene pairs were identified, many of which were commonly regulated by signaling through multiple TLRs and were involved in the cytokine responses to infection by group B
Streptococcus
. We focused on elucidating the function of one lncRNA, named
lnc‐MARCKS
or
ROCKI
(Regulator of Cytokines and Inflammation), which was induced by multiple TLR stimuli and acted as a master regulator of inflammatory responses.
ROCKI
interacted with APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) to form a ribonucleoprotein complex at the
MARCKS
promoter. In turn,
ROCKI
–APEX1 recruited the histone deacetylase HDAC1, which removed the H3K27ac modification from the promoter, thus reducing
MARCKS
transcription and subsequent Ca
2+
signaling and inflammatory gene expression. Finally, genetic variants affecting
ROCKI
expression were linked to a reduced risk of certain inflammatory and infectious disease in humans, including inflammatory bowel disease and tuberculosis. Collectively, these data highlight the importance of
cis
‐acting lncRNAs in TLR signaling, innate immunity, and pathophysiological inflammation.
Synopsis
Activation of Toll‐like receptors (TLRs) induced expression changes in lncRNAs that regulate their neighboring genes involved in inflammation. A lncRNA named
ROCKI
forms a ribonucleoprotein complex and controls inflammatory responses via chromatin modification.
More than 200
cis
‐acting lncRNAs and protein‐coding gene pairs were identified in TLR‐stimulated macrophages.
Lnc‐MARCKS
, also designated
ROCKI
, is a master regulator of inflammatory responses to TLR ligands.
ROCKI
interacts with APEX1 and HDAC1 enzymes at the
MARCKS
promoter.
ROCKI
expression is significantly associated with inflammation‐ and infection‐related disease phenotypes in humans.
Graphical Abstract
Genome‐wide identification of
cis
‐acting lncRNAs that regulate gene expression in response to infection identify a Toll‐like receptor‐induced upstream regulator of calcium signalling and inflammation processes, associated with inflammatory or infectious disease pathologies in humans. |
---|---|
ISSN: | 0261-4189 1460-2075 1460-2075 |
DOI: | 10.15252/embj.2018100041 |